PharmaJet Partner Nykode Therapeutics Announces Phase 1/2 Clinical Trial With Next Generation DNA-Based COVID-19 Vaccine Candidates
The DNA-based vaccines will be delivered intramuscularly in the clinical trial exclusively using the PharmaJet Stratis Needle-free Injection…